vtak: the income statement

MyFinsight

For the quarter ending 2025-09-30, VTAK made -$93K in revenue. -$2,251K in net income. Net profit margin of 2420.43%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total other income (expenses), net	755	-1,722	-1,194	-
Interest income	-	-	-	7
Loss from operations before income tax benefit (provision)	-2,266	-6,408	-4,769	-
Change in fair value of royalties payable	-	-	-	-1,233
Income tax benefit (provision)	78	-950	-724	-
Interest expenses	-	-	-	32
Net loss	-2,344	-5,458	-	-
Other operating income (expense), net	-	-	-	-1,261
Less net loss attributable to non-controlling interest	-93	-349	-	-
Net loss attributable to catheter precision, inc	-2,251	-5,109	-4,045	-4,120
Net income (loss) available to common stockholders, diluted	-	-	-	-4,120

Basic & diluted eps	-	-	-	-2.01
Net loss per share attributable to catheter precision, inc., basic and diluted (in dollars per share)	-1.7	-0.38	-0.36	-
Weighted-average common shares used in computing net loss per share, basic and diluted (in shares)	1,320,554	13,336,088	11,283,929	-